Skip to main content
Erschienen in: Clinical Rheumatology 5/2008

01.05.2008 | Brief Report

Hearing difficulties are common in patients with rheumatoid arthritis

verfasst von: Louisa Murdin, Sanjeev Patel, Josephine Walmsley, Lam Hoe Yeoh

Erschienen in: Clinical Rheumatology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Rheumatoid arthritis (RA) is well known to affect many different organ systems. Previous work suggests that this includes the auditory system and that measures of hearing may be related to indices of RA disease activity. The aims of this study were to determine whether hearing loss in young subjects with rheumatoid arthritis is greater than would be expected in the normal population and whether disease activity or duration correlate with hearing levels. About 55 patients (less than 50 years old) with RA were sampled from a secondary-care-level population. Pure-tone audiograms, transient evoked otoacoustic emissions (TEOAEs) and rheumatological assessment including disease duration and the DAS28 disease activity score were carried out. Subjective hearing loss was a common symptom with a prevalence of 29.6% (95% CI 17.8–42.2%). The prevalence of conductive hearing loss was 1.9% (95% CI 0.3–9.7%)). Subjects with RA had worse hearing than expected at low and middle frequencies (250 Hz to 2 kHz). TEOAEs were absent in 15 of 84 (18%, 95% CI 11–27%) normal ears. No relationship was demonstrated between hearing thresholds and markers of disease activity or other rheumatological parameters. Hearing loss is common in young people with RA and should be sought by clinicians caring for this patient population. TEOAEs are absent in a higher proportion of patients than expected, and this may be a marker of early asymptomatic hearing loss. It may be conductive or sensorineural and may take any configuration, including low-frequency loss.
Literatur
1.
Zurück zum Zitat Turesson C, O’Fallon WM, Crowson CS et al (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62:722–72PubMedCrossRef Turesson C, O’Fallon WM, Crowson CS et al (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62:722–72PubMedCrossRef
2.
Zurück zum Zitat Elwany S, Garf A, Kamel T (1986) Hearing and middle ear function in rheumatoid arthritis. J Rheumatol 13:878–881PubMed Elwany S, Garf A, Kamel T (1986) Hearing and middle ear function in rheumatoid arthritis. J Rheumatol 13:878–881PubMed
3.
Zurück zum Zitat Magaro M, Altomonte Z, Mirone L et al (1990) Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheum 8:487–490 Magaro M, Altomonte Z, Mirone L et al (1990) Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheum 8:487–490
4.
Zurück zum Zitat Takatsu M, Higaki M, Kinoshita H et al (2005) Ear involvement in patients with rheumatoid arthritis. Otol Neurotol 26:755–761PubMedCrossRef Takatsu M, Higaki M, Kinoshita H et al (2005) Ear involvement in patients with rheumatoid arthritis. Otol Neurotol 26:755–761PubMedCrossRef
5.
Zurück zum Zitat alvinelli F, Cancilleri F, Casale M et al (2004) Hearing thresholds in patients affected by rheumatoid arthritis. Clin Otolaryngol 29:75–79CrossRef alvinelli F, Cancilleri F, Casale M et al (2004) Hearing thresholds in patients affected by rheumatoid arthritis. Clin Otolaryngol 29:75–79CrossRef
6.
Zurück zum Zitat Jung T, Rhee C-K, Lee C et al (1993) Ototoxicity of salicylate, nonsteroidal anti-inflammatory drugs and quinine. Otolaryngol Clin North Am 26:791–812PubMed Jung T, Rhee C-K, Lee C et al (1993) Ototoxicity of salicylate, nonsteroidal anti-inflammatory drugs and quinine. Otolaryngol Clin North Am 26:791–812PubMed
7.
Zurück zum Zitat Marioni G, Perin N, Tregnaghi A et al (2004) Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis. Acta Oto-Laryngol 124:603–607CrossRef Marioni G, Perin N, Tregnaghi A et al (2004) Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis. Acta Oto-Laryngol 124:603–607CrossRef
8.
Zurück zum Zitat Toone E, Hayden D, Ellman H (1965) Ototoxicity of chloroquine. Arthritis Rheum 8:475–476 Toone E, Hayden D, Ellman H (1965) Ototoxicity of chloroquine. Arthritis Rheum 8:475–476
9.
Zurück zum Zitat Kastianioudakis I, Skevas A, Danielidis V et al (1995) Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol 109:713–718 Kastianioudakis I, Skevas A, Danielidis V et al (1995) Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol 109:713–718
10.
Zurück zum Zitat Ozcan A, Yalcin S, Kaygusuz I et al (2004) High frequency hearing loss and middle ear involvement in rheumatoid arthritis. Am J Otolaryngol 25:411–417CrossRef Ozcan A, Yalcin S, Kaygusuz I et al (2004) High frequency hearing loss and middle ear involvement in rheumatoid arthritis. Am J Otolaryngol 25:411–417CrossRef
11.
Zurück zum Zitat Goodwill C, Lord I, Jones R (1972) Hearing in rheumatoid arthritis: a clinical and audiometric survey. Ann Rheum Dis 31:170–173PubMedCrossRef Goodwill C, Lord I, Jones R (1972) Hearing in rheumatoid arthritis: a clinical and audiometric survey. Ann Rheum Dis 31:170–173PubMedCrossRef
12.
Zurück zum Zitat Arnett F, Edworthy S, Bloch D et al (1988) The 1987 revised ARA criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315PubMedCrossRef Arnett F, Edworthy S, Bloch D et al (1988) The 1987 revised ARA criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315PubMedCrossRef
13.
Zurück zum Zitat Prevoo M, van’t Hof M, Kuper H et al (1995) Modified disease activity scores that include twenty-eight joint counts. Arthitis Rheum 38:44–48CrossRef Prevoo M, van’t Hof M, Kuper H et al (1995) Modified disease activity scores that include twenty-eight joint counts. Arthitis Rheum 38:44–48CrossRef
14.
Zurück zum Zitat British Society of Audiology (1992) Recommended procedure for tympanometry. Br J Audiol 26:255–257CrossRef British Society of Audiology (1992) Recommended procedure for tympanometry. Br J Audiol 26:255–257CrossRef
15.
Zurück zum Zitat British Society of Audiology (2004) Recommended procedure for pure tone air and bone conduction threshold audiometry with and without masking and determination of uncomfortable loudness levels. Accessed online at http://www.thebsa.org.uk July 2007 British Society of Audiology (2004) Recommended procedure for pure tone air and bone conduction threshold audiometry with and without masking and determination of uncomfortable loudness levels. Accessed online at http://​www.​thebsa.​org.​uk July 2007
16.
Zurück zum Zitat Davis A (1995) Hearing in adults. Whurr, London, UK Davis A (1995) Hearing in adults. Whurr, London, UK
17.
Zurück zum Zitat Liening D, Larouere M (1997) Relief of sensorineural hearing loss due to rheumatoid arthritis by endolymphatic sac decompression. J Otolaryngol 26:281–283PubMed Liening D, Larouere M (1997) Relief of sensorineural hearing loss due to rheumatoid arthritis by endolymphatic sac decompression. J Otolaryngol 26:281–283PubMed
18.
Zurück zum Zitat Salvinelli F, D’Ascanio L, Casale M (2004) Staging rheumatoid arthritis: what about otoacoustic emissions? Acta Otolaryngol 124:874–875PubMedCrossRef Salvinelli F, D’Ascanio L, Casale M (2004) Staging rheumatoid arthritis: what about otoacoustic emissions? Acta Otolaryngol 124:874–875PubMedCrossRef
19.
Zurück zum Zitat Robinette M (1992) Clinical observations with transient otoacoustic emissions with adults. Semin Hear 13:23–36 Robinette M (1992) Clinical observations with transient otoacoustic emissions with adults. Semin Hear 13:23–36
20.
Zurück zum Zitat Bonfils P, Bertrand Y, Uziel A (1988) Evoked otoacoustic emissions: normative data and presbyacusis. Audiology 27:27–35PubMedCrossRef Bonfils P, Bertrand Y, Uziel A (1988) Evoked otoacoustic emissions: normative data and presbyacusis. Audiology 27:27–35PubMedCrossRef
21.
Zurück zum Zitat Desai A, Reed D, Cheyne A et al (1999) Absence of otoacoustic emissions in subjects with normal audiometric thresholds implies exposure to noise. Noise Health 1:58–65PubMed Desai A, Reed D, Cheyne A et al (1999) Absence of otoacoustic emissions in subjects with normal audiometric thresholds implies exposure to noise. Noise Health 1:58–65PubMed
Metadaten
Titel
Hearing difficulties are common in patients with rheumatoid arthritis
verfasst von
Louisa Murdin
Sanjeev Patel
Josephine Walmsley
Lam Hoe Yeoh
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 5/2008
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0802-z

Weitere Artikel der Ausgabe 5/2008

Clinical Rheumatology 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.